Back to Results
First PageMeta Content
Oncolytic virus / Adenoviridae / ORCA / Prostate cancer / Cancer research / Medicine / Viruses / Experimental cancer treatments


Press release Grant T1 patent 4JUL2011
Add to Reading List

Document Date: 2014-07-10 04:38:52

Open Document

File Size: 61,99 KB

Share Result on Facebook

City

Amsterdam / /

Company

ORCA Therapeutics BV / VCN Biosciences / /

Country

Netherlands / /

/

Event

Business Partnership / M&A / /

Facility

Catalan Institute of Oncology / VU University Medical Center / /

IndustryTerm

oncolytic adenovirus technology th / biopharmaceutical / oncolytic adenovirus technology / technology displaying / treatment of cancer / cancer treatment / /

MedicalCondition

cancer / infected tumor / human tumors / prostate cancer / different cancer / /

MedicalTreatment

anticancer therapies / /

Organization

VU University Medical Center / Catalan Institute of Oncology / European Patent Office / Department of Medical Oncology / /

Person

Manel Cascallo / Ramon Alemany / Janneke Meulenberg / /

/

Position

CEO / /

PublishedMedium

Cancer Research / /

Technology

T1 technology / T1 oncolytic adenovirus technology / /

URL

www.orca-therapeutics.com / /

SocialTag